Pipofezine
Clinical data | |
---|---|
Trade names | Azafen, Azaphen |
Routes of administration | Oral |
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C16H19N5O |
Molar mass | 297.362 g·mol−1 |
Pipofezine, sold under the brand name Azafen or Azaphen, is a tricyclic antidepressant approved in Russia for the treatment of depression.[1][2][3][4] It was introduced in the late 1960s and is still used today.[5][6]
Pipofezine has been shown to act as a potent
antiadrenergic actions are less clear but are likely.[citation needed
]
See also
References
- S2CID 23923093.
- ISBN 3-88763-075-0.
- ISBN 3-7692-2114-1.
- ISBN 978-0-12-374766-2.
- PMID 5392529.
- PMID 16281382.
- PMID 7198493.
- PMID 6142583.
- ISBN 978-0-12-374766-2.